Evidence map›Paper›PMID 28294142›Full record

ArticleScientific reports2017

Inosine attenuates spontaneous activity in the rat neurogenic bladder through an A

Claire Doyle, Vivian Cristofaro, Bryan S Sack, Stefan N Lukianov, Mattias Schäfer, Yeun Goo Chung, Maryrose P Sullivan, Rosalyn M Adam

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Activation of AExperimental and therapeutic medicine · 2022
    Article
  9. Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Enhancement of inosine-mediated ACellular signalling · 2018
    Article
  16. Inosine - a Multifunctional Treatment for Complications of Neurologic Injury.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Claire DoyleUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Vivian CristofaroDepartment of Surgery, Harvard Medical School, Boston, MA, USA.
Bryan S SackUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Stefan N LukianovUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Mattias SchäferUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Yeun Goo ChungUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Maryrose P SullivanDepartment of Surgery, Harvard Medical School, Boston, MA, USA.
Rosalyn M AdamUrological Diseases Research Center, Boston Children's Hospital, Boston, MA, USA.
Boston Children's Hospital · USHarvard University · USBrigham and Women's Hospital · USVA Boston Healthcare System · US

Funding

Urethral Tissue BioengineeringP50DK065298 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ADAM, ROSALYN M · 2003 to 2012
$9.8M
MECHANOTRANSDUCTION IN BLADDER SMOOTH MUSCLER01DK077195 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ADAM, ROSALYN M · 2008 to 2018
$3.4M
Research Training in Pediatric Urology/CHB T32T32DK060442 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ADAM, ROSALYN M · 2002 to 2023
$2.5M
Effect of Type II Diabetes on Bladder FunctionI01BX001790 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MARYROSE P SULLIVAN · 2013 to 2026
–
BLRD VA I01 BX001790NIDDK NIH HHS P50 DK065298NIDDK NIH HHS R01 DK077195NIDDK NIH HHS T32 DK060442
6 · The paper itself

Abstract

Neurogenic detrusor overactivity (NDO) is among the most challenging complications of spinal cord injury (SCI). A recent report by us demonstrated an improvement in NDO in SCI rats following chronic systemic treatment with the purine nucleoside inosine. The objective of this study was to investigate the mechanism of action of inosine underlying improvement of NDO. Male Sprague-Dawley rats underwent complete spinal cord transection at T8. Inosine (1 mM) delivered intravesically to SCI rats during conscious cystometry significantly decreased the frequency of spontaneous non-voiding contractions. In isolated tissue assays, inosine (1 mM) significantly decreased the amplitude of spontaneous activity (SA) in SCI bladder muscle strips. This effect was prevented by a pan-adenosine receptor antagonist CGS15943, but not by A

Indexed as

Adenosine A2 Receptor AntagonistsAnimalsDisease Models, AnimalHumansInosinePotassium ChannelsRatsReceptor, Adenosine A2ASpinal Cord InjuriesSulfonamidesTriazinesTriazolesUrinary Bladder, NeurogenicUrinary Bladder, OveractiveXanthinesAdenosine A2 Receptor AntagonistsInosinePotassium ChannelsPSB603Receptor, Adenosine A2ASulfonamidesTriazinesTriazolesXanthinesZM 241385

Identifiers

PMID28294142
PMCPMC5353659
OpenAlexW2606346439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.